Novo Nordisk(MX:NVON)
MX$756.20-9.80 (-1.28%)
MX:NVON
Novo Nordisk earnings date
MX$756.20
At close:-9.80 (-1.28%)
Novo Nordisk (NVON) Q1 2023 Earnings Report
1 Followers
MX:NVON Q1 2023 EPS Results
- Actual EPS
- MXN 12.05
- Consensus EPS
- MXN 11.54
- Beat/Miss
- Beat by +MXN 0.50
- One Year Ago EPS
- MXN 8.20
MX:NVON Q1 2023 Revenue Results
- Actual Revenue
- MXN 143.01B
- Expected Revenue
- MXN 142.35B
- Beat/Miss
- Beat by +MXN 655.71M
- YoY Revenue Growth
- +21.40%
Earnings Announcement Details
- Quarter
- Q1 2023
- Date
- 05/04/2023
- Time
- Before Open
- Conference Call
- Thursday, May 4, 2023
MX:NVON Upcoming Earnings
Novo Nordisk's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q1 2023 Earnings Call Audio
MX:NVON Q1 2023 Earnings Call
0:00 / 0:00
Q1 2023 Earnings Slide Deck
Q1 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NVON Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 12.31- | 17.73 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 13.5916.17 | 12.86 | 25.72% (+3.31) | |
| Aug 04, 2026 | 2026 (Q2) | 14.3117.75 | 17.27 | 2.80% (+0.48) | |
| May 06, 2026 | 2026 (Q1) | 16.4319.39 | 18.5 | 4.82% (+0.89) | |
| Feb 04, 2026 | 2025 (Q4) | 17.1617.73 | 16.47 | 7.67% (+1.26) | |
| Nov 05, 2025 | 2025 (Q3) | 14.2012.86 | 16.38 | -21.45% (-3.51) | |
| Aug 06, 2025 | 2025 (Q2) | 17.0817.27 | 12.23 | 41.19% (+5.04) | |
| May 07, 2025 | 2025 (Q1) | 17.0118.50 | 15.13 | 22.24% (+3.36) | |
| Feb 05, 2025 | 2024 (Q4) | 15.4516.47 | 13.31 | 23.74% (+3.16) | |
| Nov 06, 2024 | 2024 (Q3) | 16.3616.38 | 13.22 | 23.91% (+3.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
